From: ADIPOQ single nucleotide polymorphisms and breast cancer in northeastern Mexican women
Immunohistochemistry | ER status n (%) | PR status n (%) | Her-2 status n (%) | TNBC status n (%) |
---|---|---|---|---|
Positive | 149 (54.4) | 127 (46.4) | 114 (41.6) | 82 (29.9) |
Negative | 125 (45.6) | 147 (53.6) | 165 (57.0) | 192 (70.1) |